All In Biotech

Investigational drug · Phase 3

SYS6002

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Urothelial Carcinoma, Cervical Cancer, Advanced Solid Tumors.

Phase 3

Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

5

5 still active

All registered trials

5

Any phase or sponsor naming "SYS6002"

First trial start

2025

Aug 30, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "SYS6002", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Urothelial Carcinoma
  • Cervical Cancer
  • Advanced Solid Tumors
  • Head and Neck Squamous Cell Carcinoma
  • Advanced Urothelial Carcinoma

Approved drugs for the same conditions: Bladder and urothelial cancer · Head and neck cancer · Cervical cancer · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "SYS6002" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Urothelial Carcinoma

  • BMS-986507BL-B01D1, Iza-brenPhase 351 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma

  • 9MW2821Phase 311 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Urothelial Carcinoma, Advanced Urothelial Carcinoma, Locally Advanced or Metastatic Triple-negative Breast Cancer

  • CetrelimabJNJ-63723283Phase 38 trials

    Johnson & Johnson (Janssen) · Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms

  • BudigalimabABBV-181Phase 36 trials

    AbbVie · Hepatocellular Carcinoma, Non Small Cell Lung Carcinoma, c-MET

  • Cretostimogene GrenadenorepvecCG0070Phase 34 trials

    CG Oncology, Inc. · Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer, Urologic Cancer

  • GimistotugBGB-A445Phase 34 trials

    BeOne Medicines (BeiGene) · Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma

  • LivmoniplimabABBV-151Phase 34 trials

    AbbVie · Hepatocellular Carcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.